Related Experiment Video
Updated: May 20, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships
1The University of Queensland, Queensland Brain Institute, Brisbane, QLD 4072, Australia. hong.lee@uq.edu.au
Bioinformatics (Oxford, England)
|July 31, 2012
Summary
This study introduces a new statistical method to estimate genetic correlations between complex traits, finding a significant positive correlation between Type 2 diabetes and hypertension risk.
Area of Science:
- Genetics
- Biostatistics
- Complex Trait Genomics
Background:
- Estimating genetic correlations between complex traits traditionally relies on pedigree studies, which can be confounded by shared environmental factors.
- Low disease prevalence can hinder accurate genetic correlation estimates for diseases due to insufficient co-aggregation in families.
- Existing methods struggle with unbiased genetic correlation estimation for complex traits, especially binary disease traits.
Purpose of the Study:
- To develop and implement statistical methods for unbiased estimation of genetic correlations between complex traits.
- To provide a robust method applicable to both quantitative and binary traits using genome-wide data.
- To apply the developed method to estimate genetic correlations between various complex diseases.
Main Methods:
- Utilized linear mixed models and genome-wide single-nucleotide polymorphism data from population-based case-control studies.
- Developed statistical approaches for estimating genetic correlations between pairs of quantitative traits and pairs of binary traits.
- Validated the novel methods through simulation studies before application.
Main Results:
- Successfully developed and implemented statistical methods for unbiased genetic correlation estimation.
- Applied the method to Wellcome Trust Case Control Consortium data, performing bivariate analyses.
- Estimated a significant positive genetic correlation of approximately 0.31 (P = 0.024) between the risk of Type 2 diabetes and hypertension.
Conclusions:
- The developed linear mixed model-based methods provide unbiased estimates of genetic correlations for complex traits.
- The findings reveal a significant shared genetic influence between Type 2 diabetes and hypertension risk.
- The freely available GCTA software facilitates the application of these advanced genetic analyses.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:54Evolutionary Relationships through Genome Comparisons
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...